University of Montreal School of Public Health, Montreal, Canada.
Centre of Genomics and Policy, McGill University, Montreal, Canada.
BMC Pregnancy Childbirth. 2019 Jan 10;19(1):22. doi: 10.1186/s12884-018-2153-y.
Canadian policies regarding the implementation and public coverage of non-invasive prenatal testing (NIPT) are heterogeneous and shifting, with NIPT being publicly covered for high-risk pregnancies in some provinces, but not others. Such a diverse and evolving policy landscape provides fertile ground for examining the preferences of pregnant women, their partners, and health professionals regarding the implementation and coverage of NIPT by the public healthcare system, as well as the factors influencing their preferences, which is what the present study does.
In this paper, we report the results of three-large scale Canadian surveys, in which 882 pregnant women, 395 partners of pregnant women, and 184 healthcare professionals participated.
The paper focuses on preferences regarding how and when NIPT should be used, as well as the factors influencing these preferences, and how coverage for NIPT should be provided. These are correlated with respondents' levels of knowledge about Down syndrome and testing technologies and with their stated intended use of NIPT results.
Salient is the marked difference between the preferences of prospective parents and those of healthcare professionals, which has potential implications for Canadian policy regarding NIPT implementation and insurance coverage.
加拿大关于非侵入性产前检测(NIPT)的实施和公共覆盖政策存在差异且不断变化,一些省份的高危妊娠可享受公共医疗保险覆盖 NIPT,但其他省份则不行。这种多样化和不断发展的政策格局为研究孕妇、其伴侣和医疗保健专业人员对公共医疗保健系统实施和覆盖 NIPT 的偏好,以及影响他们偏好的因素提供了有利条件,这正是本研究的目的。
本文报告了三项大型加拿大调查的结果,共有 882 名孕妇、395 名孕妇的伴侣和 184 名医疗保健专业人员参与了调查。
本文重点关注了关于 NIPT 应该如何以及何时使用,以及影响这些偏好的因素,以及应该如何提供 NIPT 覆盖的问题。这些问题与受访者对唐氏综合征和检测技术的了解程度以及他们对 NIPT 结果的预期用途有关。
准父母和医疗保健专业人员的偏好之间存在显著差异,这对加拿大关于 NIPT 实施和保险覆盖的政策具有潜在影响。